These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27173155)

  • 21. The use of beta-blockers in the treatment of chronic heart failure.
    Rudisill PT; Kennedy C; Paul S
    Crit Care Nurs Clin North Am; 2003 Dec; 15(4):439-46. PubMed ID: 14717388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-adrenergic blockade in chronic heart failure: principles, progress, and practice.
    Packer M
    Prog Cardiovasc Dis; 1998; 41(1 Suppl 1):39-52. PubMed ID: 9715822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced aortocoronary sinus extraction of epinephrine in patients with left ventricular failure secondary to long-term pressure or volume overload.
    Rose CP; Burgess JH; Cousineau D
    Circulation; 1983 Aug; 68(2):241-4. PubMed ID: 6861302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive Function and the Ageing Process: The Peculiar Role of Mild Thyroid Failure.
    Pasqualetti G; Caraccio N; Dell Agnello U; Monzani F
    Recent Pat Endocr Metab Immune Drug Discov; 2016; 10(1):4-10. PubMed ID: 27396589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adrenergic nervous system in heart failure.
    Esler M; Kaye D; Lambert G; Esler D; Jennings G
    Am J Cardiol; 1997 Dec; 80(11A):7L-14L. PubMed ID: 9412538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What constitutes optimal neurohumoral antagonism in chronic heart failure?
    Tajik AA; Dickstein K
    Heart; 2016 Dec; 102(23):1922-1932. PubMed ID: 27742799
    [No Abstract]   [Full Text] [Related]  

  • 27. Sympathetic activation in heart failure and its treatment with beta-blockade.
    Pepper GS; Lee RW
    Arch Intern Med; 1999 Feb; 159(3):225-34. PubMed ID: 9989534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rationale for treatment of patients with chronic heart failure with adrenergic blockade.
    Sackner-Bernstein JD; Mancini DM
    JAMA; 1995 Nov; 274(18):1462-7. PubMed ID: 7474194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta blocker treatment in heart failure.
    Carson PE
    Prog Cardiovasc Dis; 1999; 41(4):301-21. PubMed ID: 10362350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sympathetic dysregulation in heart failure: mechanisms and therapy.
    Mark AL
    Clin Cardiol; 1995 Mar; 18(3 Suppl I):I3-8. PubMed ID: 7743696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of adrenergic blockade on plasma adrenomedullin concentration during static handgrip in patients with heart failure.
    Krzemiński K; Nazar K; Cybulski G; Mikulski T
    Clin Physiol Funct Imaging; 2006 Nov; 26(6):328-34. PubMed ID: 17042897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sympathetic activation and the role of beta-blockers in chronic heart failure.
    Krum H
    Aust N Z J Med; 1999 Jun; 29(3):418-27. PubMed ID: 10868514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cellular and physiologic effects of beta blockers in heart failure.
    Sabbah HN
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Switching from Cilnidipine to Azelnidipine on Cardiac Sympathetic Nerve Function in Patients with Heart Failure Preserved Ejection Fraction.
    Kiuchi S; Hisatake S; Kabuki T; Oka T; Dobashi S; Fujii T; Ikeda T
    Int Heart J; 2018 Jan; 59(1):120-125. PubMed ID: 29269711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure.
    Kaye DM; Lambert GW; Lefkovits J; Morris M; Jennings G; Esler MD
    J Am Coll Cardiol; 1994 Mar; 23(3):570-8. PubMed ID: 8113536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-adrenergic blocking agents in the treatment of congestive heart failure: mechanisms and clinical results.
    Doughty RN; Sharpe N
    Annu Rev Med; 1997; 48():103-14. PubMed ID: 9046949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-adrenergic component of the sympathetic nervous system in congestive heart failure.
    Leier CV; Binkley PF; Cody RJ
    Circulation; 1990 Aug; 82(2 Suppl):I68-76. PubMed ID: 2164897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of functional capacity and survival in congestive heart failure. Effects of activation of the sympathetic nervous system.
    Packer M
    Postgrad Med; 1988 Feb; Spec No():96-103. PubMed ID: 2894667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is activation of the sympathetic nervous system beneficial or detrimental to the patient with chronic heart failure? Lessons learned from clinical trials with beta-adrenergic agonists and antagonists.
    Packer M
    J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S38-43. PubMed ID: 2478808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure.
    Esler M; Kaye D
    J Auton Nerv Syst; 1998 Oct; 72(2-3):210-9. PubMed ID: 9851571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.